Want to join the conversation?
$LM FY15 10-K: As of March 31, 2015, total assets were $7.07Bil vs. $7.11Bil as of March 31, 2014. Total liabilities were $2.54Bil vs. $2.34Bil at FY14-end. Long-term debt was $1.06Bil vs. $1.04Bil at FY14-end. Cash and cash equivalents were $669.55MM vs. $858.02MM at FY14-end. Dividends declared per share were $0.64 vs. $0.52 in FY14.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.